Darolutamide

Short Description:

API’s Name Indication Innovator Patent Expiry Date(The U.S)
Darolutamide prostatic cancer treatment Bayer  Mar. 25,2033


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us